Exane Derivatives Citigroup Inc Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Citigroup Inc stock. As of the latest transaction made, Exane Derivatives holds 50,565 shares of C stock, worth $3.95 Million. This represents 1.49% of its overall portfolio holdings.
Number of Shares
50,565
Previous 40,273
25.56%
Holding current value
$3.95 Million
Previous $2.15 Million
8.14%
% of portfolio
1.49%
Previous 0.67%
Shares
18 transactions
Others Institutions Holding C
# of Institutions
2,241Shares Held
1.38BCall Options Held
76.9MPut Options Held
94.5M-
Vanguard Group Inc Valley Forge, PA166MShares$13 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY160MShares$12.5 Billion0.23% of portfolio
-
State Street Corp Boston, MA83.5MShares$6.53 Billion0.24% of portfolio
-
Geode Capital Management, LLC Boston, MA40.6MShares$3.17 Billion0.23% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD38.6MShares$3.01 Billion0.31% of portfolio
About CITIGROUP INC
- Ticker C
- Exchange NYSE
- Sector Financial Services
- Industry Banks—Diversified
- Shares Outstandng 1,936,710,016
- Market Cap $151B
- Description
- Citigroup Inc., a diversified financial services holding company, provides various financial products and services to consumers, corporations, governments, and institutions in North America, Latin America, Asia, Europe, the Middle East, and Africa. The company operates in two segments, Global Consumer Banking (GCB) and Institutional Clients Grou...